CLLD8 / SETDB2 polyclonal, anti-human

Background:
Proteins that contain a SET domain, such as SETDB2, modulate gene expression epigenetically through histone H3 (see MIM 601128) methylation. SETDB2 is likely a histone H3 methyltransferase, as it contains both the active site and flanking cysteine residues required for catalytic activity (Zhang et al., 2003 [PubMed 12754510]).

Other Names:
Histone-lysine N-methyltransferase SETDB2, 2.1.1.43, Chronic lymphocytic leukemia deletion region gene 8 protein, Lysine N-methyltransferase 1F, SET domain bifurcated 2, SETDB2, C13orf4, CLLD8, KMT1F

Antigen Types:
Synthetic Peptide

Gene Name:
SETDB2
Gene ID:
83852
Primary Accession: Q96T68
Other Accession: NP_001153780;83852;